Wilson Sonsini Goodrich & Rosati advised Nvelop Therapeutics on intellectual property matters related to the transaction. Chroma Medicine and Nvelop Therapeutics announced their merger and subsequent...
Nvelop Therapeutics’ Merger with Chroma
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Prime Medicine’s $161.0 Million Common Stock Offering
Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
Arena BioWorks’ Launch
Wilson Sonsini Goodrich & Rosati advised Arena BioWorks on patent and transactional matters. Arena BioWorks announced its launch as a biomedical research institute with a mission...